Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Final regular trade
09/20/2024 16:00:00 EDT X 11.60 1007192 NS
Interesting trades today
Buy: 480KNeutral: 197KSell: 110K
Following marked as stock option trades.
One big buy
09//20/2024 14:15:52 EDT V 11.90 207300 ND
And a sell
09/20/2024 14:15:58 EDT V 11.88 124400 NDD
Unusual opening trade
09/20/2024 9:30:00 EDT X 12.45 109766 NS
You got your million shares.
Unusual we are up almost a dollar and HALO is down 2.43.
Futures up +492.
What is the point of these 1 share trades?
Date/Time Price Shares Exch/Mkt
09/18/2024 19:13:42 EDT I 11.99 1 NDD
09/18/2024 16:56:38 EDT I 11.13 1 EDGX
09/18/2024 16:37:56 EDT W 11.42 88223
This painting the tape I like. Doubt it holds.
09/17/2024 16:40:09 EDT I 11.93 14 NDD
Any concern about the Malibu earthquake?
What did I miss? The call didn’t seem that great to me for a jump of 1.58.
V= stock option trade
09/09/2024 15:34:35 EDT V 8.76 257800 NDD
09/09/2024 15:34:25 EDT V 8.76 128900
09/09/2024 15:34:15 EDT V 8.76 128900
From Seeking Alpha
Avid Bioservices Q1 2025 Earnings Preview
Sep. 08, 2024 5:35 PM ETAvid Bioservices, Inc. (CDMO) StockBy: Pranav Ghumatkar, SA News Editor
Play
(<1min)
Avid Bioservices (NASDAQ:CDMO) is scheduled to announce Q1 earnings results on Monday, September 9th, after market close.
The consensus EPS Estimate is -$0.04 (-33.3% Y/Y) and the consensus Revenue Estimate is $40.82M (+8.3% Y/Y).
Over the last 2 years, CDMO has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
September 3, 2024 at 4:05 PM EDT
Download PDF
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the first quarter of fiscal year 2025 on September 9, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time). Members of Avid's senior management will discuss financial results for the first quarter and review recent corporate developments.
To listen to the live webcast, or access the archived webcast, please visit: http://ir.avidbio.com/investor-events.
About Avid Bioservices, Inc.
Avid Bioservices (NASDAQ:CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com
20 day not 200?
I couldn’t agree more. The BOD should have raised the roof about no repercussions to Hart and Zeibell. The good ol’ boy network is alive and strong. Anyone there ever hear of “fiduciary duty”?
Interesting long article today in the NYT by Maureen Dowd on Alex Karp, Peter Theil and Palentir.
https://www.nytimes.com/2024/08/17/style/alex-karp-palantir.html?smid=nytcore-ios-share&referringSource=articleShare
HALO has been on a tear. Up another 1.60 to $61. Up $10 in the last week or so.
08/19/2024 7:00:00 EDT I 11.33 44 NSD
08/19/2024 7:00:00 EDT I 11.33 48 NSD
08/19/2024 7:00:00 EDT I 11.24 48 ARCA
08/19/2024 7:00:00 EDT I 11.56 92 EDGX
08/19/2024 7:00:00 EDT I 11.25 8 EDGX
Lots of AH activity. 884,369 sh
08/15/2024 16:13:41 EDT T 10.68 299143 NDD
08/15/2024 16:13:10 EDT T 10.68 138899 NDD
08/15/2024 16:02:36 EDT P 10.68 330 NDD
08/15/2024 16:02:06 EDT P 10.68 374 NDD
08/15/2024 16:01:54 EDT P 10.68 600 NDD
08/15/2024 16:01:36 EDT I 10.68 30 NDD
08/15/2024 16:01:34 EDT T 10.68 110200 NDD
08/15/2024 16:01:18 EDT P 10.68 636 NDD
08/15/2024 16:01:07 EDT T 10.68 119500 NDD
08/15/2024 16:00:49 EDT T 10.68 79600 NDD
08/15/2024 16:00:32 EDT T 10.68 128742 NDD
08/15/2024 16:00:11 EDT P 10.68 2425 NDD
08/15/2024 16:00:11 EDT P 10.68 306 NDD
08/15/2024 16:00:10 EDT P 10.68 400 NDD
08/15/2024 16:00:01 EDT T 10.68 884 NDD
08/15/2024 16:00:01 EDT T 10.68 307 NDD
08/15/2024 16:00:00 EDT I 10.68 2 NDD
08/15/2024 16:00:00 EDT T 10.68 200 NDDr
08/15/2024 16:13:41 EDT T 10.68 299143 NDD
08/15/2024 16:13:10 EDT T 10.68 138899 NDD
08/15/2024 16:02:36 EDT P 10.68 330 NDD
08/15/2024 16:02:06 EDT P 10.68 374 NDD
08/15/2024 16:01:54 EDT P 10.68 600 NDD
08/15/2024 16:01:36 EDT I 10.68 30 NDD
08/15/2024 16:01:34 EDT T 10.68 110200 NDD
08/15/2024 16:01:18 EDT P 10.68 636 NDD
08/15/2024 16:01:07 EDT T 10.68 119500 NDD
08/15/2024 16:00:49 EDT T 10.68 79600 NDD
08/15/2024 16:00:32 EDT T 10.68 128742 NDD
08/15/2024 16:00:11 EDT P 10.68 2425 NDD
08/15/2024 16:00:11 EDT P 10.68 306 NDD
08/15/2024 16:00:10 EDT P 10.68 400 NDD
08/15/2024 16:00:01 EDT T 10.68 884 NDD
08/15/2024 16:00:01 EDT T 10.68 307 NDD
08/15/2024 16:00:00 EDT I 10.68 2 NDD
2024 16:00:00 EDT T 10.68 200 NDD
08/15/2024 16:00:00 EDT T 10.68 900 NDD
08/15/2024 16:00:00 EDT I 10.68 68 NDD
08/15/2024 16:00:00 EDT T 10.68 280 NDD
08/15/2024 16:00:00 EDT T 10.68 120 NDD
08/15/2024 16:00:00 EDT T 10.68 100 NDD
08/15/2024 16:00:00 EDT T 10.68 320 NDD
08/15/2024 16:00:00 EDT X 10.68 124809 NSD
Some trading at $11 this morning,
08/15/2024 9:31:57 EDT F 11.00 2865 NSD
08/15/2024 9:31:57 EDT I 11.00 2 NSD
08/15/2024 9:31:57 EDT I 11.00 10 NSD
08/15/2024 9:31:57 EDT F 11.00 500 NSD
08/15/2024 9:31:57 EDT I 10.99 16 NSD
08/15/2024 9:31:57 EDT I 10.99 5 CBOE BZX
08/15/2024 9:31:57 EDT F 10.99 100 NSD
08/15/2024 9:31:57 EDT I 10.99 5 NSD
08/15/2024 9:31:57 EDT F 10.99 100 NSD
08/15/2024 9:31:47 EDT F 10.99 100 MIAX
08/15/2024 9:31:27 EDT 11.00 100 NDD
Green trade notation was stock option trade
8/13/2024 13:18:08 EDT V 10.73 86000 NDD
CNN
—
A magnitude 4.4 earthquake occurred in Los Angeles at 12:20 p.m. PT, according to the US Geological Survey. The quake had an initial reported intensity of 4.7 but has since been revised down to 4.4.
The shallow quake was only 7.5 miles deep and directly under the populated areas of Los Angeles, so was likely felt widely despite the relatively modest intensity.
A US Geological Survey map marks the epicenter and range of a 5.2 magnitude earthquake that struck near Bakersfield, California on August 6.
RELATED ARTICLE
5.2 magnitude earthquake near Bakersfield rumbles through Southern California
Earthquakes of magnitudes 4 to 5 generally bring light shaking and very light to no damage.
According to stocktadotcom the chart is very bullish.
CDMO Analysis
CDMO Avid Bioservices Inc Add to Watch List FAQ
Symbol
CDMO
Last Trade
10.57
Date
Aug-12-2024
Change
0.04
Open
10.58
High
10.58
Low
10.48
Volume
5,747
Note: Canadian symbols now end in .c i.e SYMB.C
Analysis
Overall
Very Bullish (0.57)
Short
Very Bullish (0.51)
Intermediate
Very Bullish (0.58)
Long
Very Bullish (0.60)
According to fintel Institutional ownership has gone from 108.72% to 110.12% today.
The next earnings call should be around 9/7.
From SeekingAlpha
Facing Valuation Risks Despite Increased Capacity
Aug. 06, 2024 6:23 PM ETAvid Bioservices, Inc. (CDMO) Stock
Myriam Alvarez profile picture
Myriam Alvarez
1.42K Followers
Play
(12min)
Summary
Avid Bioservices expanded its revenue capacity from $120 million to over $400 million, focusing on CGT.
CDMO specializes in cGMP for mammalian cell culture products, ensuring compliance with FDA standards.
The company's backlog increased slightly to $193 million in Q4 2024, indicating steady future revenue potential.
Despite positive growth prospects, financial underperformance and valuation concerns led to a "Sell" rating on the stock.
3d render. Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. COVID-19 mRNA vaccine production platform.
wacomka
Avid Bioservices, Inc. (NASDAQ:CDMO) is a leading contract development and manufacturing organization with over 30 years of expertise in the biopharmaceutical industry. The company serves biotech firms that develop biological treatments for cancer, autoimmune disorders, and infectious diseases. CDMO specializes in current good manufacturing practices [cGMP] for products derived from mammalian cell culture, assuring FDA-revised quality and safety standards in the manufacturing processes. CDMO has also expanded into the cell and gene therapy [CGT] sector and boosted its revenue-generating capacity from $120 million to over $400 million. CDMO is well-positioned to capitalize on the ongoing onshoring drug production trend, generating new opportunities for steady growth. However, despite the positives, CDMO continues to underperform financially. Its mounting losses and my valuation concerns on the stock led to rate CDMO a “Sell.”
Pharma Manufacturing: Business Overview
Avid Bioservices is a contract development and manufacturing organization with over 30 years of experience in biopharmaceutical production. CDMO provides manufacturing services for firms that develop innovative biological treatments for conditions like cancer, autoimmune disorders, and infectious diseases at the clinical and commercial stages. The company specializes in current good manufacturing practices [cGMP] for biopharmaceutical products from mammalian cell culture, encompassing processes for producing biological therapies
Amazing CDMO is green. The only stock on my watch list that isn’t red.
Almost 230K traded AH. Several large lots.
08/01/2024 16:33:55 EDT I 9.91 9 ARCA
08/01/2024 16:33:55 EDT I 10.07 1 NSD
08/01/2024 16:07:59 EDT T 10.47 27889 NDD
08/01/2024 16:06:22 EDT T 10.47 27388 NDD
08/01/2024 16:06:19 EDT I 10.15 1 ARCA
08/01/2024 16:06:08 EDT T 10.47 27388 NDD
08/01/2024 16:04:02 EDT P 10.47 118585 NDD
08/01/2024 16:01:54 EDT P 10.47 1474 NDD
08/01/2024 16:01:49 EDT P 10.47 106 NDD
08/01/2024 16:01:41 EDT P 10.47 2750 NDD
08/01/2024 16:01:29 EDT P 10.47 1619 NDD
08/01/2024 16:01:27 EDT P 10.47 459 NDD
08/01/2024 16:01:24 EDT P 10.47 478 NDD
08/01/2024 16:01:21 EDT P 10.47 1180 NDD
08/01/2024 16:01:19 EDT I 10.47 67 NDD
08/01/2024 16:01:17 EDT P 10.47 251 NDD
08/01/2024 16:01:12 EDT P 10.47 146 NDD
08/01/2024 16:00:14 EDT P 10.47 217 NDD
08/01/2024 16:00:14 EDT P 10.47 604 NDD
08/01/2024 16:00:14 EDT P 10.47 683 NDD
08/01/2024 16:00:14 EDT P 10.47 1899 NDD
08/01/2024 16:00:14 EDT P 10.47 1589
Heavy AH trading
End time:
Go
Export
Date/Time Price Shares Exch/Mkt
07/30/2024 16:01:43 EDT P 10.23 787 NDD
07/30/2024 16:01:40 EDT P 10.23 137 NDD
07/30/2024 16:01:37 EDT P 10.23 787 NDD
07/30/2024 16:01:31 EDT T 10.23 169900 NDD
07/30/2024 16:01:25 EDT P 10.23 3504 NDD
07/30/2024 16:01:20 EDT P 10.23 259 NDD
07/30/2024 16:01:18 EDT P 10.23 2228 NDD
07/30/2024 16:01:17 EDT T 10.23 169900 NDD
07/30/2024 16:01:12 EDT P 10.23 2380 NDD
07/30/2024 16:01:10 EDT P 10.23 118 NDD
07/30/2024 16:01:08 EDT P 10.23 101 NDD
07/30/2024 16:01:06 EDT P 10.23 549 NDD
07/30/2024 16:00:11 EDT P 10.23 307 NDD
07/30/2024 16:00:11 EDT P 10.23 149 NDD
07/30/2024 16:00:11 EDT I 10.23 5 NDD
07/30/2024 16:00:11 EDT P 10.23 1800 NDD
07/30/2024 16:00:11 EDT P 10.23 1319 NDD
07/30/2024 16:00:11 EDT P 10.23 1099 NDD
07/30/2024 16:00:11 EDT P 10.23 10300 NDD
07/30/2024 16:00:11 EDT P 10.23 700 NDD
07/30/2024 16:00:00 EDT I 10.23 12 NDD
07/30/2024 16:00:00 EDT T 10.23 100 NDD
07/30/2024 16:00:00 EDT X 10.23 192160
This is the latest shown on nasdaq.com
Settlement Date Short Interest Avg. Daily Share Volume Days to Cover
07/15/2024 12,311,618 1,034,321 11.903092
06/28/2024 12,358,079 1,235,553 10.002063
06/14/2024 15,076,940 820,884 18.366712
05/31/2024 11,510,830 805,811 14.284776
05/15/2024 11,862,647 1,220,692 9.717969
04/30/2024 11,056,967 1,071,600 10.318185
04/15/2024 10,322,378 984,233 10.487738
03/28/2024 10,110,394 1,114,601 9.070864
03/15/2024 10,842,004 2,873,857 3.772632
02/29/2024 6,593,041 894,032 7.374502
02/15/2024 5,649,903 992,362 5.693389
01/31/2024 5,229,426 936,240 5.585561
01/12/2024 5,539,603 1,021,195 5.424628
What??
07/26/2024 16:05:26 EDT T 11.22 24842 NDD
07/26/2024 16:05:20 EDT T 11.22 24843 NDD
A decent sized but
07/24/2024 11:36:26 EDT 9.50 153000 NDD
Volume picking up the last few minutes.
Thanks for finding that. I guess we won’t be seeing $40.
Large AH trade
07/12/2024 17:23:24 EDT W 8.32 184268 NDD
07/12/2024 16:06:17 EDT I 8.51 1 ARCA
07/12/2024 16:02:52 EDT P 8.32 321 NDD
07/12/2024 16:02:50 EDT P 8.32 105 NDD
07/12/2024 16:02:47 EDT P 8.32 771 NDD
07/12/2024 16:02:46 EDT P 8.32 136 NDD
07/12/2024 16:02:44 EDT P 8.32 503 NDD
07/12/2024 16:02:40 EDT P 8.32 3238 NDD
07/12/2024 16:02:37 EDT P 8.32 1268 NDD
07/12/2024 16:02:19 EDT I 8.32 69 NDD
07/12/2024 16:02:01 EDT P 8.32 1304 NDD
07/12/2024 16:01:40 EDT P 8.32 212 NDD
07/12/2024 16:01:37 EDT P 8.32 672 NDD
07/12/2024 16:01:15 EDT P 8.32 2438 NDD
07/12/2024 16:00:11 EDT I 8.32 83 NDD
07/12/2024 16:00:11 EDT P 8.32 1767 NDD
07/12/2024 16:00:11 EDT P 8.32 473 NDD
07/12/2024 16:00:11 EDT P 8.32 335 NDD
07/12/2024 16:00:11 EDT P 8.32 226 NDD
07/12/2024 16:00:11 EDT P 8.32 2235
Finally some good news the market is reacting positively to. Thanks.
HALO is up $20 this year, from $33 to $53. Wish we would see some of that in our share price.
-Thanks.
A 40 cent spread seems excessive. Bid 7.60 ask 8.00.. R